Abbott reports positive Simcor trial results

11/4/2007 | CNNMoney

Abbott Laboratories' cholesterol-lowering treatment Simcor significantly reduced "bad" LDL cholesterol and improved "good" HDL cholesterol compared to simvastatin during its Phase III clinical trial. The company hopes to get regulatory approval for Simcor, a combination of simvastatin and another drug from Abbott, during the first quarter of 2008.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI